missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-21 Protein
Click to view available options
Quantité:
10 μg
50 μg
Conditionnement:
10µg
50µg
Description
The Recombinant Human IL-21 Protein is derived from E. coli. The Recombinant Human IL-21 Protein has been validated for the following applications: Bioactivity.

Spécification
Spécification
Numéro d’adhésion | Q9HBE4 |
À utiliser avec (application) | Bioactivity |
Formule | Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. |
Identification génétique (Entrez) | 59067 |
Poids moléculaire | Observed M.W.: 17kDa, reducing conditions, Theoretical M.W.: 15kDa |
Quantité | 10 μg |
Source | E. coli-derived human IL-21 protein Gln25-Ser155,with a N-terminal Met |
Conditions de stockage | 12 months from date of receipt, ≤ -20° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution. |
Concentration en endotoxines | <0.10 EU per 1μg of the protein by the LAL method. |
Alias de gène | IL21, IL-21Za11interleukin-21, interleukin 21, interleukin-21 isoform |
Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu